Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaud Guille

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Journal of Personalized Medicine|May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone TherapyMathias Neron, Arnaud Guille, Lucie Allegre, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2024
Absence of chromosome axis protein recruitment prevents meiotic recombination chromosome-wide in the budding yeast <i>Lachancea kluyveri</i>Sylvain Legrand, Asma Saifudeen, Hélène Bordelet, et al.
Journal of Translational Medicine|June 23, 2023
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO networkElsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, et al.
EMBO Molecular Medicine|August 3, 2022
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALTAlexandre de Nonneville, Sébastien Salas, François Bertucci, et al.
Cancers|February 25, 2022
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer PatientsAlexia Lopresti, Claire Acquaviva, Laurys Boudin, et al.
Blood|October 7, 2024
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significanceCamille Laurent, Preeti Trisal, Bruno Tesson, et al.
Plos One|January 14, 2014
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingStéphanie Cornen, Arnaud Guille, José Adélaïde, et al.
Molecular Oncology|December 20, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancersFrançois Bertucci, Charlotte Rypens, Pascal Finetti, et al.
Cell Death & Disease|February 3, 2022
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cellsViolette Azzoni, Julien Wicinski, Manon Macario, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2021
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patientsCecile Vicier, Patrick Sfumato, Nicolas Isambert, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Personalized Medicine|May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone TherapyMathias Neron, Arnaud Guille, Lucie Allegre, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2024
Absence of chromosome axis protein recruitment prevents meiotic recombination chromosome-wide in the budding yeast <i>Lachancea kluyveri</i>Sylvain Legrand, Asma Saifudeen, Hélène Bordelet, et al.
Journal of Translational Medicine|June 23, 2023
Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO networkElsa Nigon, Claudia Lefeuvre-Plesse, Alejandra Martinez, et al.
EMBO Molecular Medicine|August 3, 2022
TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALTAlexandre de Nonneville, Sébastien Salas, François Bertucci, et al.
Cancers|February 25, 2022
Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer PatientsAlexia Lopresti, Claire Acquaviva, Laurys Boudin, et al.
Blood|October 7, 2024
Follicular lymphoma comprises germinal center-like and memory-like molecular subtypes with prognostic significanceCamille Laurent, Preeti Trisal, Bruno Tesson, et al.
Plos One|January 14, 2014
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingStéphanie Cornen, Arnaud Guille, José Adélaïde, et al.
Molecular Oncology|December 20, 2019
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancersFrançois Bertucci, Charlotte Rypens, Pascal Finetti, et al.
Cell Death & Disease|February 3, 2022
BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cellsViolette Azzoni, Julien Wicinski, Manon Macario, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2021
TAKTIC: A prospective, multicentre, uncontrolled, phase IB/II study of LY2780301, a p70S6K/AKT inhibitor, in combination with weekly paclitaxel in HER2-negative advanced breast cancer patientsCecile Vicier, Patrick Sfumato, Nicolas Isambert, et al.
Pageof 5